Johnson & Johnson: Stelara fares well in Crohn's disease
Monday, October 19, 2015 - 09:00
in Health & Medicine
TRENTON, N.J. (AP) -- Johnson & Johnson's immune disorder drug Stelara significantly reduced symptoms of the inflammatory bowel condition Crohn's disease with just one infusion in about half the patients tested, according to the company....